Search details
1.
Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection.
Cell
; 184(1): 76-91.e13, 2021 01 07.
Article
in English
| MEDLINE | ID: mdl-33147444
2.
Cycling cancer persister cells arise from lineages with distinct programs.
Nature
; 596(7873): 576-582, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34381210
3.
An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1.
Br J Cancer
; 128(9): 1647-1664, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36810913
4.
YES1 amplification is a mechanism of acquired resistance to EGFR inhibitors identified by transposon mutagenesis and clinical genomics.
Proc Natl Acad Sci U S A
; 115(26): E6030-E6038, 2018 06 26.
Article
in English
| MEDLINE | ID: mdl-29875142
5.
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
Proc Natl Acad Sci U S A
; 113(42): E6409-E6417, 2016 10 18.
Article
in English
| MEDLINE | ID: mdl-27702896
6.
De novo selection of oncogenes.
Proc Natl Acad Sci U S A
; 111(1): E6-E14, 2014 Jan 07.
Article
in English
| MEDLINE | ID: mdl-24344264
7.
Next-generation sequencing of paired tyrosine kinase inhibitor-sensitive and -resistant EGFR mutant lung cancer cell lines identifies spectrum of DNA changes associated with drug resistance.
Genome Res
; 23(9): 1434-45, 2013 Sep.
Article
in English
| MEDLINE | ID: mdl-23733853
8.
Isolation of epithelial, endothelial, and immune cells from lungs of transgenic mice with oncogene-induced lung adenocarcinomas.
Am J Respir Cell Mol Biol
; 52(4): 409-17, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25347711
9.
The Evolution of Mouse Models of Cancer: Past, Present, and Future.
Cold Spring Harb Perspect Med
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38772706
10.
Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer.
J Thorac Oncol
; 19(2): 240-251, 2024 02.
Article
in English
| MEDLINE | ID: mdl-37806385
11.
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer Res
; 84(8): 1303-1319, 2024 04 15.
Article
in English
| MEDLINE | ID: mdl-38359163
12.
EGFR-Driven Lung Adenocarcinomas Co-opt Alveolar Macrophage Metabolism and Function to Support EGFR Signaling and Growth.
Cancer Discov
; : OF1-OF22, 2024 Jan 25.
Article
in English
| MEDLINE | ID: mdl-38270272
13.
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma.
Nat Commun
; 15(1): 1532, 2024 Feb 20.
Article
in English
| MEDLINE | ID: mdl-38378697
14.
EGFR-driven lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth.
Cancer Discov
; 2024 Jan 19.
Article
in English
| MEDLINE | ID: mdl-38241033
15.
Patient-Derived Models of Cancer in the NCI PDMC Consortium: Selection, Pitfalls, and Practical Recommendations.
Cancers (Basel)
; 16(3)2024 Jan 29.
Article
in English
| MEDLINE | ID: mdl-38339316
16.
Effect of Dietary Supplementation with a Mixture of Natural Antioxidants on Milk Yield, Composition, Oxidation Stability and Udder Health in Dairy Ewes.
Antioxidants (Basel)
; 12(8)2023 Aug 06.
Article
in English
| MEDLINE | ID: mdl-37627566
17.
Overexpressed Malat1 Drives Metastasis through Inflammatory Reprogramming of Lung Adenocarcinoma Microenvironment.
bioRxiv
; 2023 Mar 23.
Article
in English
| MEDLINE | ID: mdl-36993368
18.
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy.
Res Sq
; 2023 Jun 01.
Article
in English
| MEDLINE | ID: mdl-37398248
19.
Challenges and opportunities for modeling aging and cancer.
Cancer Cell
; 41(4): 641-645, 2023 04 10.
Article
in English
| MEDLINE | ID: mdl-37001528
20.
EGFR + lung adenocarcinomas coopt alveolar macrophage metabolism and function to support EGFR signaling and growth.
bioRxiv
; 2023 Apr 17.
Article
in English
| MEDLINE | ID: mdl-37131637